A contrast-enhanced breast MRI is an imaging test that uses a strong magnetic field and an injected gadolinium dye to produce detailed breast images. It detects cancers, evaluates the extent of disease, and clarifies unclear mammogram or ultrasound findings, often used for high‑risk screening or preoperative staging. It involves no ionizing radiation, takes about 30–60 minutes, and may be contraindicated with severe kidney disease or certain implants.

Most routine mammograms use no contrast. When contrast-enhanced mammography (CEM) is done, an iodine-based (iodinated) intravenous contrast agent—the same type used for CT—is injected to highlight areas of increased blood supply and improve lesion detection. Gadolinium is used for breast MRI, not mammography; iodinated agents have usual allergy and kidney-function considerations.

A breast MRI with contrast is generally safe for most people. MRI uses strong magnets, so some metal implants or devices may be contraindicated. Gadolinium contrast rarely causes allergic reactions; in people with severe kidney impairment there is a small risk of nephrogenic systemic fibrosis, so kidney function may be checked beforehand. Evidence of harmful gadolinium retention is minimal. Pregnancy and device issues may prompt alternatives; breastfeeding can usually continue.

MRI contrast agents are typically gadolinium-based paramagnetic chelates given intravenously to enhance blood vessels, inflammation, and tumors on T1-weighted images. Common formulations are macrocyclic or linear gadolinium chelates. They are generally safe but used cautiously in severe kidney impairment because of a rare risk of nephrogenic systemic fibrosis; clinicians usually check renal function before administration.

A breast MRI with contrast is generally not painful. Most people feel only a brief pinch when the IV is inserted and a short warm or metallic sensation during the contrast injection. You may notice pressure from the breast coil, loud noises, or discomfort from lying still; anxiety or claustrophobia can increase distress. Serious reactions are rare—report any unusual symptoms immediately.

Gadolinium-based MRI contrast agents are generally safe for most people. Serious allergic reactions are rare. People with severe kidney impairment face risk of nephrogenic systemic fibrosis, so kidney function is screened before use. Small amounts of gadolinium can deposit in tissues; health effects are unclear. Use the lowest effective dose and avoid in pregnancy unless essential. Discuss risks and alternatives with your clinician.